Revelation Biosciences, Inc. (REVB) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
REVB EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
REVB Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export REVB earnings history in CSV or JSON format
Free sign-in required to download data
Revelation Biosciences, Inc. (REVB) Earnings Overview
As of May 8, 2026, Revelation Biosciences, Inc. (REVB) reported trailing twelve-month net income of -$16M, reflecting +72.7% year-over-year growth. The company earned $-4.85 per diluted share over the past four quarters.
Looking at the long-term picture, REVB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3,638 in fiscal 2019.
Revelation Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ADMA ($165M net income, 28.8% margin), AGEN ($115,000 net income, 0.1% margin), IMVT (-$464M net income), REVB has comparable earnings metrics. Compare REVB vs ADMA →
REVB Earnings vs Peers
Earnings metrics vs comparable public companies
REVB Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$9M | +40.7% | -$9M | $-23.95 | - | - |
| 2024 | -$15M | -12405.6% | -$8M | $-87.68 | - | - |
| 2023 | $-120,254 | +98.9% | -$9M | $-8.41 | - | - |
| 2022 | -$11M | +9.7% | -$11M | $-9643.37 | - | - |
| 2021 | -$12M | -635.2% | -$12M | $-20400.00 | - | - |
| 2020 | -$2M | -44718.6% | -$4M | $-9032.69 | - | - |
| 2019 | $-3,638 | - | $-3,638 | $-6.72 | - | - |
See REVB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs REVB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare REVB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonREVB — Frequently Asked Questions
Quick answers to the most common questions about buying REVB stock.
Is REVB growing earnings?
REVB EPS is $-4.85, with earnings growth accelerating to +72.7%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-16M.
What are REVB's profit margins?
Revelation Biosciences, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are REVB's earnings?
REVB earnings data spans 2019-2025. The accelerating earnings trend is +72.7% YoY. Historical data enables comparison across business cycles.